SCHEMBL16673038

SCHEMBL16673038

Cc1ccccc1C(=O)OCCc1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 5/20 0.67
▸ L3MBTL1 Q9Y468 5/20 0.67
▸ ALDH1A1 P00352 3/20 0.67
▸ HPGD P15428 3/20 0.67
▸ SMN1; SMN2 Q16637 3/20 0.67
▸ TDP1 Q9NUW8 3/20 0.67
▸ NPC1 O15118 2/20 0.67
▸ RAB9A P51151 2/20 0.67
▸ CYP3A4 P08684 2/20 0.67
▸ MAPK1 P28482 2/20 0.67
▸ TP53 P04637 1/20 0.67
▸ GLA P06280 1/20 0.67
▸ HIF1A Q16665 1/20 0.67
▸ HSD17B10 Q99714 1/20 0.67
▸ ESR1 P03372 1/20 0.55
▸ ESR2 Q92731 1/20 0.55
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ GPR52 Q9Y2T5 1/20 0.51
▸ SCN1A P35498 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17797782 0.89 TSHR (0.66) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL28030065 0.88 TSHR (0.52) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL5695885 0.88 KMT2A (0.64) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL290777 0.88 TSHR (0.77) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL27352937 0.87 TSHR (0.70) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL10309778 0.85 TSHR (0.57) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL29860961 0.85 LMNA (0.61) TSHRL3MBTL1ALDH1A1SMN1; SMN2TDP1
SCHEMBL16049266 0.84 TSHR (0.59) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL8433421 0.84 TSHR (0.59) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2
SCHEMBL17797867 0.84 TSHR (0.59) TSHRL3MBTL1ALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250360066-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE ROKA FURADADA S L (ES) 2025-11-27 — — US claimed
EP-4561523-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE Roka Furadada, SL (ES) 2025-06-04 — — EP claimed
WO-2024023286-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE ROKA FURADADA, S.L. (ES) 2024-02-01 — — WO claimed
US-20250360066-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE ROKA FURADADA S L (ES) 2025-11-27 — — US disclosed
EP-4561523-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE Roka Furadada, SL (ES) 2025-06-04 — — EP disclosed
EP-4561523-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE Roka Furadada, SL (ES) 2025-06-04 — — EP disclosed
CN-108136227-B Solubilizers for functionally active compounds ISP投资有限公司 2024-12-10 — — CN disclosed
US-20240374492-A1 A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION ISP INVESTMENTS LLC (US) 2024-11-14 — — US disclosed
WO-2024023286-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE ROKA FURADADA, S.L. (ES) 2024-02-01 — — WO disclosed
WO-2024023286-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE ROKA FURADADA, S.L. (ES) 2024-02-01 — — WO disclosed
WO-2023009315-A1 A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION ISP INVESTMENTS LLC (US) 2023-02-02 — — WO disclosed
EP-2869389-B1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME MITSUBISHI CHEM CORP (JP) 2019-11-13 — — EP disclosed
US-10320030-B2 Nonaqueous electrolyte solution and nonaqueous electrolyte battery employing the same MITSUBISHI CHEMICAL CORPORATION (JP) 2019-06-11 — — US disclosed
US-20150140448-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY EMPLOYING THE SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2015-05-21 — — US disclosed
EP-2869389-A1 NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTIC SOLUTION CELL USING SAME Mitsubishi Chemical Corporation (JP) 2015-05-06 — — EP disclosed
US-20140107135-A1 PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AUSPEX PHARMACEUTICALS, INC. (US) 2014-04-17 — — US disclosed
CN-102057027-B Improvements relating to fabric conditioners UNILEVER 2013-04-10 — — CN disclosed
CN-102057028-B Improvements relating to fabric conditioners UNILEVER NV 2012-10-10 — — CN disclosed
CN-102057028-A Improvements relating to fabric conditioners UNILEVER NV 2011-05-11 — — CN disclosed
CN-102057027-A Improvements relating to fabric conditioners UNILEVER 2011-05-11 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250360066-A1 COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE TYR, PAH, ERCC4 TSHR 3024/4885L3MBTL1 4885/4885ALDH1A1 888/4885
US-20140107135-A1 PYRIMIDINONE INHIBITORS OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 PLA2G1B, PLA2G4A, PLA2G4B TSHR 3285/4885L3MBTL1 3877/4885ALDH1A1 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback